
Ivan Patrick Maillard MD PhD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Professor of Medicine and Vice-Chief for Research, Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine
1275 York AvenueNew York, NY 10065
Overview of Dr. Maillard
Dr. Ivan Maillard is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Hospital of the University of Pennsylvania. He received his medical degree from University of Lausanne Faculty of Medicine and has been in practice 24 years. Dr. Maillard accepts several types of health insurance, listed below. He is one of 38 doctors at Hospital of the University of Pennsylvania and one of 71 doctors at Memorial Sloan Kettering Cancer Center who specialize in Hematology. He also speaks multiple languages, including French, German, and Portuguese. He has more than 100 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2005
University of Lausanne Faculty of MedicineClass of 1993
Certifications & Licensure
NY State Medical License 2024 - 2026
PA State Medical License 2001 - 2024
MI State Medical License 2007 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- A common progenitor gives rise to fibroblastic reticular cells and vascular smooth muscle cells in murine lymph nodes.Lisa Kurz, Mechthild Lütge, Angelina De Martin, Hung-Wei Cheng, Elina Bugar
The Journal of Experimental Medicine. 2026-02-02 - 1 citationsIntrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis.Benjamin M Kahn, Raymond W S Ng, Il-Kyu Kim, Cody Eskandarian, Chelsey O Chen
Cancer Discovery. 2025-09-04 - 1 citationsEarly Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation.Dave Maurice De Sousa, Eric Perkey, Laure Le Corre, Salix Boulet, Daniela Gómez Atria
The Journal of Experimental Medicine. 2025-05-05
Journal Articles
- Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersMatthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
- The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaDale L Bixby, Ivan P Maillard, Moshe Talpaz, Leukemia Research
- Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in MiceIvan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood
- Join now to see all
Abstracts/Posters
- Dll1 and Dll4 Notch Ligands Prime T Cell Alloimmunity and Are Expressed in Non-Overlapping Populations of Fibroblastic Stromal Cells in Spleen and Lymph Nodes at the O...Ivan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeIvan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic TransformationIvan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Stromal Cell Immune Regulation in the Microenvironment61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Pharmacologic Blockade of Notch/Delta-like Ligand 4 Signaling Protects from Gastrointestinal Acute Graft-Versus-Host Disease in Non-Human Primates2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaJune 2018
Press Mentions
A Crucial Mechanism in Immune Response: NOTCH Signaling Pathway Plays Essential Role in CD8⁺ T Cell DifferentiationMarch 25th, 2025
Montreal Study Provides Insight into How T Lymphocytes WorkMarch 20th, 2025
Genome Toxicity and Impaired Stem Cell Function After Conditional Activation of CreERT2 in the IntestineNovember 15th, 2018- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- French, German, Portuguese
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









